Influenza vaccination in patients with multiple sclerosis.
Vaccination was well tolerated by 93 patients with multiple sclerosis who received a total of 209 doses of influenza vaccine. In one patient, evidence of a new lesion developed after vaccination; the relapse rate was less than would be expected in the natural course of the illness. Toxic and allergic reactions appeared with 7% and 0.5% of the vaccinations, respectively--a rate no higher than that observed in the general population.
D000208:Acute Disease; D002555:Cerebrospinal Fluid / Q000166:cytology; D002559:Cerebrospinal Fluid Rhinorrhea / Q000209:etiology; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects*; D008214:Lymphocytes; D009103:Multiple Sclerosis / Q000150:complications*; D012008:Recurrence; D013997:Time Factors
D007252:Influenza Vaccines